• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巩膜厚度随访氟轻松水合物植入(Retisert)后。

Scleral thickness following fluocinolone acetonide implant (Retisert).

机构信息

Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Ocul Immunol Inflamm. 2010 Aug;18(4):305-13. doi: 10.3109/09273941003658292.

DOI:10.3109/09273941003658292
PMID:20482407
Abstract

PURPOSE

To evaluate whether intravitreal fluocinolone acetonide (FA) implantation (Retisert) leads to scleral thinning.

METHODS

Scleral thickness was measured at the pars plana region (4 quadrants) with anterior segment OCT (Visante) in FA implanted eyes (18) with noninfectious posterior uveitis in comparison to eyes with prior vitrectomy (8), and normal eyes without prior surgery (30).

RESULTS

Mean scleral thickness in normal (nonsurgical) eyes was 0.99/0.93/0.88/0.86, and 0.92 mm in the inferonasal/inferotemporal/superotemporal/superonasal quadrants, and overall, respectively. Sclera was thinner in each quadrant of the FA implanted eyes compared to the fellow or nonsurgical eyes, although none reached statistical significance, as the differences were small. However, a few FA implanted eyes demonstrated more dramatic scleral thinning than others.

CONCLUSIONS

FA implant appears to lead to statistically nonsignificant scleral thinning overall with few exceptions. Clinicians should be aware of potential scleral thinning in select cases, important for reimplantation and long-term follow-up.

摘要

目的

评估玻璃体内氟轻松醋酸酯(FA)植入(Retisert)是否导致巩膜变薄。

方法

使用眼前节 OCT(Visante)在患有非传染性后葡萄膜炎的 FA 植入眼(18 只眼)的平面区域(4 象限)测量巩膜厚度,并与玻璃体切割术(8 只眼)和无先前手术史的正常眼(30 只眼)进行比较。

结果

正常(非手术)眼的平均巩膜厚度分别为 0.99/0.93/0.88/0.86,鼻下/颞下/颞上/鼻上象限分别为 0.92mm,总体上分别为 0.92mm。与对侧眼或非手术眼相比,FA 植入眼的每个象限的巩膜均变薄,尽管差异均无统计学意义,但差异较小。然而,少数 FA 植入眼的巩膜变薄程度比其他眼更明显。

结论

FA 植入物似乎导致总体上统计学上无显著巩膜变薄,但有少数例外。临床医生应注意在某些情况下可能发生的巩膜变薄,这对于再次植入和长期随访很重要。

相似文献

1
Scleral thickness following fluocinolone acetonide implant (Retisert).巩膜厚度随访氟轻松水合物植入(Retisert)后。
Ocul Immunol Inflamm. 2010 Aug;18(4):305-13. doi: 10.3109/09273941003658292.
2
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.用于非感染性后葡萄膜炎的醋酸氟轻松植入剂(Retisert):一项多中心随机临床研究的34周结果
Ophthalmology. 2006 Jun;113(6):1020-7. doi: 10.1016/j.ophtha.2006.02.021. Epub 2006 May 9.
3
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.醋酸氟轻松植入剂治疗后葡萄膜炎的一项试点试验的长期随访结果
Ophthalmology. 2005 Jul;112(7):1192-8. doi: 10.1016/j.ophtha.2005.03.013.
4
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.评价玻璃体内注射氟轻松醋酸酯植入剂与标准全身治疗在非感染性后部葡萄膜炎中的效果。
Ophthalmology. 2010 Mar;117(3):567-75, 575.e1. doi: 10.1016/j.ophtha.2009.11.027. Epub 2010 Jan 15.
5
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.氟轻松(Retisert)与地塞米松(Ozurdex)玻璃体内植入物治疗葡萄膜炎的比较。
J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7. doi: 10.1089/jop.2012.0180. Epub 2013 Jan 8.
6
Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.联合氟轻松醋酸酯玻璃体腔内植入和青光眼引流装置植入治疗慢性葡萄膜炎和青光眼。
Am J Ophthalmol. 2010 May;149(5):800-6.e1. doi: 10.1016/j.ajo.2009.12.009. Epub 2010 Feb 26.
7
Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.氟轻松丙酮缩醇缓释植入剂用于慢性葡萄膜炎的再植入
Am J Ophthalmol. 2008 Apr;145(4):667-675. doi: 10.1016/j.ajo.2007.11.008. Epub 2008 Jan 28.
8
Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).氟轻松醋酸酯眼内植入剂(Retisert)治疗儿童难治性后葡萄膜炎。
Retina. 2012 Mar;32(3):537-42. doi: 10.1097/IAE.0b013e31822058bb.
9
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.使用醋酸氟轻松植入物治疗后葡萄膜炎:三年临床试验结果。
Arch Ophthalmol. 2008 Sep;126(9):1191-201. doi: 10.1001/archopht.126.9.1191.
10
Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.氟轻松醋酸酯缓释植入剂(Retisert)自发解离并脱位至前房。
Ocul Immunol Inflamm. 2015;23(6):454-7. doi: 10.3109/09273948.2014.902074. Epub 2015 Aug 27.

引用本文的文献

1
A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future.感染性和非感染性葡萄膜炎的眼部给药平台及药物综述:过去、现在与未来
Pharmaceutics. 2021 Aug 8;13(8):1224. doi: 10.3390/pharmaceutics13081224.
2
Anterior eye tissue morphology: Scleral and conjunctival thickness in children and young adults.眼前节组织形态:儿童和青年人群巩膜和结膜厚度。
Sci Rep. 2016 Sep 20;6:33796. doi: 10.1038/srep33796.
3
Measurement of Scleral Thickness in Humans Using Anterior Segment Optical Coherent Tomography.
使用眼前节光学相干断层扫描技术测量人类巩膜厚度
PLoS One. 2015 Jul 28;10(7):e0132902. doi: 10.1371/journal.pone.0132902. eCollection 2015.
4
Metrics of the normal anterior sclera: imaging with optical coherence tomography.正常前巩膜的测量指标:光学相干断层扫描成像
Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1575-80. doi: 10.1007/s00417-015-3072-5. Epub 2015 Jun 12.
5
Scleral melt following Retisert intravitreal fluocinolone implant.雷珠单抗玻璃体内注射氟轻松植入术后巩膜溶解
Drug Des Devel Ther. 2014 Nov 28;8:2373-5. doi: 10.2147/DDDT.S66634. eCollection 2014.
6
Scleral thickness in human eyes.人眼球巩膜厚度。
PLoS One. 2012;7(1):e29692. doi: 10.1371/journal.pone.0029692. Epub 2012 Jan 6.